Search
Now showing items 1-1 of 1
A PK2/Bv8/PROK2 antagonist suppresses tumorigenic processes by inhibiting angiogenesis in glioma and blocking myeloid cell infiltration in pancreatic cancer.
(2011)
In many cancer types, infiltration of bone marrow-derived myeloid cells in the tumor
microenvironment is often associated with enhanced angiogenesis and tumor progression,
resulting in poor prognosis. The polypeptide chemokine ...